Fundraising FoxEmboline
Santa Cruz, US · Delaware corporation · 4 known investors
Find your way into Emboline
Sign up to see every warm intro you have to Emboline
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Emboline team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Emboline develops the Emboliner Embolic Protection System, a cerebral protection device aimed at preventing stroke during transcatheter aortic valve replacement (TAVR) procedures. The company serves interventional cardiologists in the structural heart and cardiovascular medical device market.
Founders & leadership
AB
Amir BelsonFounder & Chief Technology OfficerAmir Belson is the founder and Chief Technology Officer of Emboline, which develops a cerebral protection device for transcatheter aortic valve replacement procedures. He has founded multiple medtech companies including Neoguide Systems (acquired by Intuitive Surgical), Vascular Pathways (acquired by C.R. Bard), and Zipline Medical (acquired by Stryker), and holds over 750 patents.
MC
Mark CairesChief Financial OfficerHe has experience in financing and M&A activities, having participated in over $200 million in funding rounds across multiple startups and managed over $50 million in cash and securities; he has also contributed to S1 regulatory filings for medical device companies.
NP
Nicholas PappasNamed on SEC filing
ES
Elton SatuskyNamed on SEC filing
EX
Eric XiaoNamed on SEC filing
JC
J. Casey McGlynnNamed on SEC filing
SR
Scott RussellPresident, Chief Executive OfficerHe previously served as president and CEO of SeptRx, co-founded SuperRenal and ConfirMD, and founded Benchmark Nitinol, where he was president for nearly a decade. Earlier he directed the Advanced Device Concepts Group at Cordis/Nitinol Devices & Components, a Johnson & Johnson company, and led sales and marketing at Shape Memory Applications; he also sat on the board of Modular Surgical from 2017 to 2023.
IM
Issam MoussaNamed on SEC filing
PC
Peng ChengNamed on SEC filing
AB
Amir Belson, M.D.Founder, Chief Technology OfficerA physician and medical device inventor, he has founded companies including Radiaction, Follisave, and Venocare, and chairs the boards of Ceretrieve, Follisave, and Venocare. He also serves as a board member at LEM Surgical, IOP Medical, Rambach MedTech, and Planterra Foods.
Investors · 4
Anthro Ventureslisted by Anthro Ventures
How we know: Anthro Ventures's portfolio page · Not right? Tell us
ShangBay Capital LLClisted by ShangBay Capital LLCPalo Alto
How we know: ShangBay Capital LLC's portfolio page · Not right? Tell us
Western Technology Investmentlisted by Western Technology InvestmentPortola Valley
How we know: westerntech.com · Not right? Tell us
Trinity CapitalreportedPhoenix
How we know: press coverage · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$86.9M disclosed across 3 of 4 rounds · 2020–2026
- $20MraisedMar 2026 · 2 sources
Trinity Capital (lead)
Source ↗ - Undisclosed amountBridge RoundJan 2020Source ↗
▶$55.4MraisedJun 2021 · 14 investors · OtherRule 506(b)
▶$55.4MraisedJun 2021 · 14 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas PappasDirector
- Elton SatuskyExecutive Officer
- Amir BelsonExecutive Officer, Director
- Eric XiaoDirector
- J. Casey McGlynnExecutive Officer
- Scott RussellExecutive Officer, Director
- Issam MoussaDirector
- Peng ChengDirector
- Offering amount
- $60.1M
- Amount sold
- $55.4M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.6MraisedFeb 2021 · 80 investors · OtherRule 506(b)
▶$11.6MraisedFeb 2021 · 80 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Scott RussellExecutive Officer, Director
- J. Casey McGlynnExecutive Officer
- Issam D. MoussaDirector
- Amir BelsonExecutive Officer, Director
- William DaiDirector
- Elton SatuskyExecutive Officer
- Peng ChengDirector
- Offering amount
- $15M
- Amount sold
- $11.6M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
EmblokEmblok develops the Emblok 360° whole body embolic protection system, a medical device used during left heart procedures such as TAVR to block and capture emboli and debris. It aims to reduce the risk of procedure-related strokes and damage to the heart, kidneys, and intestines for physicians and patients.
Companies working in the same space as Emboline.
In the news
Frequently asked questions
- What does Emboline do?
- Emboline develops the Emboliner Embolic Protection System, a cerebral protection device aimed at preventing stroke during transcatheter aortic valve replacement (TAVR) procedures. The company serves interventional cardiologists in the structural heart and cardiovascular medical device market.
- Who founded Emboline?
- Emboline was founded by Amir Belson.
- Who are Emboline's investors?
- Emboline's investors include Anthro Ventures, ShangBay Capital LLC, Western Technology Investment, Trinity Capital.
- How much funding has Emboline raised?
- Emboline has disclosed $86.9M raised across 3 of its 4 known rounds.
- Where is Emboline headquartered?
- Emboline is headquartered in Santa Cruz, US.